A Study of Disitamab Vedotin + Bicalutamide in HER2/AR-Positive Scrotal Paget's Disease

Clinical trial NCT07117851 · RECRUITING

Trial details

NCT number: NCT07117851
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Extramammary Paget Disease Scrotum Disease

Start date: 2025-08-01
Primary completion: 2027-12-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.